Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taste and Local Tolerance of NLA Nasal Spray in Allergic Rhinitis
NCT00533637Phase 2Completed
- Sponsor
- Biolipox AB
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cetirizine in allergic rhinitis (AR), sponsored by Biolipox AB. Started Sep 2007; status: completed.
02
Drugs
cetirizine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00533637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00533637.